AMRX Stock Summary and Trading Ideas (Amneal Pharmaceuticals - Class A | NASDAQ:AMRX)

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Amneal Pharmaceuticals - Class A trades on the NASDAQ stock market under the symbol AMRX.

As of December 13, 2024, AMRX stock price declined to $7.83 with 666,306 million shares trading.

AMRX has a beta of 0.95, meaning it tends to be less sensitive to market movements. AMRX has a correlation of 0.10 to the broad based SPY ETF.

AMRX has a market cap of $2.42 billion. This is considered a Mid Cap stock.

Last quarter Amneal Pharmaceuticals - Class A reported $702 million in Revenue and $.16 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.03.

In the last 3 years, AMRX traded as high as $9.48 and as low as $1.24.

The top ETF exchange traded funds that AMRX belongs to (by Net Assets): VTI, IWM, VB, VBR, VXF.

AMRX has outperformed the market in the last year with a return of +66.2%, while the SPY ETF gained +29.9%. However, in the most recent history, AMRX shares have underperformed the stock market with its stock returning -9.2% in the last 3 month period and -5.3% for the last 2 week period, while SPY has returned +7.8% and +0.3%, respectively.

AMRX support price is $7.73 and resistance is $8.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMRX shares will trade within this expected range on the day.